Comprehensive Development of CAR-T Cell Therapy in Taiwan:GDP Laboratory and Cell Processing_2023.11.22
Comprehensive Development of CAR-T Cell Therapy in Taiwan:DLBCL Disease Treatment Strategies and Optimization of Treatment Outcomes_2023.12.22
![](https://cartcelltherapy-taiwan.com/wp-content/uploads/2024/01/螢幕擷取畫面-2024-01-09-103753.jpg)
線上會議影音檔
Comprehensive Development of CAR-T Cell Therapy in Taiwan:Nursing Care for Patients and Side Effect Management_2023.12.06
![](https://cartcelltherapy-taiwan.com/wp-content/uploads/2024/01/螢幕擷取畫面-2024-01-09-101407.jpg)
線上會議影音檔
Reverse translational research of CAR-T therapy_2023.11.02
– Analysis of some 500 cases of CAR-T therapy for B-cell lymphoma in Japan –
Shin Kawamata, MD Phd
Comprehensive Development of CAR-T Cell Therapy in Taiwan:Recent Advances and Future Perspectives in CAR-T Cell Therapy Industry in Asia_2023.11.02
![](https://cartcelltherapy-taiwan.com/wp-content/uploads/2023/11/2023-11-17-10-55-44.jpg)
線上會議影音檔
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Comprehensive Development of CAR-T Cell Therapy in Taiwan:Recent Advances and Future Perspectives in CAR-T Cell Therapy Industry in Asia
![](https://cartcelltherapy-taiwan.com/wp-content/uploads/2023/10/iamge-home-02-1024x652.jpg)
會議形式:Virtual Panel
Meeting(線上與談會議)